Cargando…

Operation start time and long-term outcome of hepatocellular carcinoma after curative hepatic resection

PURPOSE: The objective of the current study was to examine the potential effects of surgery start times (morning vs. afternoon) on the long-term prognosis of patients after hepatic resection (HR) for hepatocellular carcinoma (HCC). METHODS: All eligible patients were divided into 2 groups according...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Qiang, Li, Qing-Shan, Zhang, Wei, Liu, Kang, Li, Tao, Yu, Jia-Wei, Lv, Yi, Zhang, Xu-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Surgical Society 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332319/
https://www.ncbi.nlm.nih.gov/pubmed/32676476
http://dx.doi.org/10.4174/astr.2020.99.1.1
_version_ 1783553506515353600
author Lu, Qiang
Li, Qing-Shan
Zhang, Wei
Liu, Kang
Li, Tao
Yu, Jia-Wei
Lv, Yi
Zhang, Xu-Feng
author_facet Lu, Qiang
Li, Qing-Shan
Zhang, Wei
Liu, Kang
Li, Tao
Yu, Jia-Wei
Lv, Yi
Zhang, Xu-Feng
author_sort Lu, Qiang
collection PubMed
description PURPOSE: The objective of the current study was to examine the potential effects of surgery start times (morning vs. afternoon) on the long-term prognosis of patients after hepatic resection (HR) for hepatocellular carcinoma (HCC). METHODS: All eligible patients were divided into 2 groups according to the start time of surgery: group M (morning surgery, 8 AM–1 PM) and group A (afternoon surgery, 1 PM–6 PM). Clinicopathologic and surgical parameters, as well as oncologic outcomes were compared between the 2 groups. RESULTS: In total, 231 patients were included in the study. There was no difference in age, body mass index, comorbidities, tumor size, tumor location, tumor stages, surgical procedures, or surgical margin between morning and afternoon surgery (all P > 0.05). In contrast, patients in group M experienced longer operation duration than those in group A (median, 240 minutes vs. 195 minutes, P = 0.004). However, no differences of overall survival were observed between morning and afternoon surgery groups in the whole cohort or stratified by surgical margin (all P > 0.05). CONCLUSION: Surgery start times during the work day have no measurable influence on patient outcome following curative HR for HCC, indicating good self-regulation and professional judgment of surgeons for progressive fatigue during surgery.
format Online
Article
Text
id pubmed-7332319
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Korean Surgical Society
record_format MEDLINE/PubMed
spelling pubmed-73323192020-07-15 Operation start time and long-term outcome of hepatocellular carcinoma after curative hepatic resection Lu, Qiang Li, Qing-Shan Zhang, Wei Liu, Kang Li, Tao Yu, Jia-Wei Lv, Yi Zhang, Xu-Feng Ann Surg Treat Res Original Article PURPOSE: The objective of the current study was to examine the potential effects of surgery start times (morning vs. afternoon) on the long-term prognosis of patients after hepatic resection (HR) for hepatocellular carcinoma (HCC). METHODS: All eligible patients were divided into 2 groups according to the start time of surgery: group M (morning surgery, 8 AM–1 PM) and group A (afternoon surgery, 1 PM–6 PM). Clinicopathologic and surgical parameters, as well as oncologic outcomes were compared between the 2 groups. RESULTS: In total, 231 patients were included in the study. There was no difference in age, body mass index, comorbidities, tumor size, tumor location, tumor stages, surgical procedures, or surgical margin between morning and afternoon surgery (all P > 0.05). In contrast, patients in group M experienced longer operation duration than those in group A (median, 240 minutes vs. 195 minutes, P = 0.004). However, no differences of overall survival were observed between morning and afternoon surgery groups in the whole cohort or stratified by surgical margin (all P > 0.05). CONCLUSION: Surgery start times during the work day have no measurable influence on patient outcome following curative HR for HCC, indicating good self-regulation and professional judgment of surgeons for progressive fatigue during surgery. The Korean Surgical Society 2020-07 2020-06-29 /pmc/articles/PMC7332319/ /pubmed/32676476 http://dx.doi.org/10.4174/astr.2020.99.1.1 Text en Copyright © 2020, the Korean Surgical Society http://creativecommons.org/licenses/by-nc/4.0/ Annals of Surgical Treatment and Research is an Open Access Journal. All articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Lu, Qiang
Li, Qing-Shan
Zhang, Wei
Liu, Kang
Li, Tao
Yu, Jia-Wei
Lv, Yi
Zhang, Xu-Feng
Operation start time and long-term outcome of hepatocellular carcinoma after curative hepatic resection
title Operation start time and long-term outcome of hepatocellular carcinoma after curative hepatic resection
title_full Operation start time and long-term outcome of hepatocellular carcinoma after curative hepatic resection
title_fullStr Operation start time and long-term outcome of hepatocellular carcinoma after curative hepatic resection
title_full_unstemmed Operation start time and long-term outcome of hepatocellular carcinoma after curative hepatic resection
title_short Operation start time and long-term outcome of hepatocellular carcinoma after curative hepatic resection
title_sort operation start time and long-term outcome of hepatocellular carcinoma after curative hepatic resection
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332319/
https://www.ncbi.nlm.nih.gov/pubmed/32676476
http://dx.doi.org/10.4174/astr.2020.99.1.1
work_keys_str_mv AT luqiang operationstarttimeandlongtermoutcomeofhepatocellularcarcinomaaftercurativehepaticresection
AT liqingshan operationstarttimeandlongtermoutcomeofhepatocellularcarcinomaaftercurativehepaticresection
AT zhangwei operationstarttimeandlongtermoutcomeofhepatocellularcarcinomaaftercurativehepaticresection
AT liukang operationstarttimeandlongtermoutcomeofhepatocellularcarcinomaaftercurativehepaticresection
AT litao operationstarttimeandlongtermoutcomeofhepatocellularcarcinomaaftercurativehepaticresection
AT yujiawei operationstarttimeandlongtermoutcomeofhepatocellularcarcinomaaftercurativehepaticresection
AT lvyi operationstarttimeandlongtermoutcomeofhepatocellularcarcinomaaftercurativehepaticresection
AT zhangxufeng operationstarttimeandlongtermoutcomeofhepatocellularcarcinomaaftercurativehepaticresection